A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk ...

The CDC has published updated recommendations for older adults, detailing who should get vaccinated against RSV. The move comes after concerns were raised earlier this year that the shot may be ...

That's partly because the vaccine may slightly increase the risk of a rare side effect that can sometimes lead to paralysis or death. RSV circulates seasonally and hospitalizes 60,000 to 160,000 ...

Since the preventive effect is the same as a vaccine, the monoclonal antibody shots to protect against RSV are often called vaccines, although that's not technically accurate. "We call these ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to 59 years old who are at increased risk for severe illness from ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include individuals 18-59 years of age who are at increased risk for severe illness from ...